Serotonin function in anxiety - II. Effects of the serotonin agonist MCPP in panic disorder patients and healthy subjects

Psychopharmacology

Volumn 92, Issue 1, 1987, Pages 14-24

  Charney, D S ^a   Woods, S W ^a   Goodman, W K ^a   Heninger, G R ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anxiety; Cortisol; Growth hormone; MCPP; Prolactin; Serotonin

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; GROWTH HORMONE; HYDROCORTISONE; PLACEBO; PROLACTIN; SEROTONIN;

BEHAVIOR; CENTRAL NERVOUS SYSTEM; DRUG EFFICACY; ETIOLOGY; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; METHODOLOGY; NORMAL HUMAN; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT;

ADULT; ANXIETY; EMOTIONS; FEAR; FEMALE; GROWTH HORMONE; HEMODYNAMICS; HUMAN; HYDROCORTISONE; MALE; PANIC; PIPERAZINES; PROLACTIN; SEROTONIN; SEX FACTORS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0023179757     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/BF00215473     Document Type: Article

References (71)

1. Serotonergic control of prolactin release in male rats
2. Neuroendocrine and behavioral effects of m-chlorophenylpiperazine administration in rhesus monkeys
3. Catecholamine inhibition of prolactin secretion by isolated rat adenohypophyses
4. Effects of serotonin receptor antagonists on punished responding maintained by stimulus-shock termination or food presentation in squirrel monkeys
5. Effects of serotonin receptor agonists and antagonists on schedule-controlled behavior of squirrel monkeys
6. (-)- m-chlorophenylpiperazine, a central 5-hydroxytryptamine agonist, is a metabolite of trazodone
7. Plasma concentrations of trazodone and 1-(3-chlorophenyl)piperazine in man after a single oral dose of trazodone
8. Rat brain serotonin: Biochemical and functional evidence for a sex difference
9. The influence of ritanserin, a serotonin antagonist, in anxiety disorders: A double-blind placebo-controlled study versus lorazepam
10. Serotonin function in panic disorders: The effect of intravenous tryptophan in healthy subjects and panic disorder patients before and during alprazolam treatment
11. Noradrenergic function in panic anxiety: Effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder
12. Increased anxiogenic effects of caffeine in panic disorders
13. Evidence that serotonin neurons stimulate secretion of prolactin releasing factor
14. Canine growth hormone responsiveness during pentobarbital anesthesia: a method for evaluating serotonergic stimulatory action
15. Anticonflict effect of the putative serotonin receptor agonist 8-hydroxy-2-(DI- n-propylamino)tetralin(8-OH-DPAT)
16. Sex steroid modulation of the serotonin behavioral syndrome
17. Serotonergic stimulation of pituitary-adrenocortical function in rats
18. Effect of serotonin-releasing drugs on serum corticosterone concentration in rats
19. Disposition and pharmacological effects of m-chlorophenylpiperazine in rats
20. Evidence that serotonin stimulates a prolactin-releasing factor in the rat
21. The effects of 5-HTP on para-chlorophenylalanine (p-CPA) attenuation of “conflict” behavior
22. Biochemical and behavioral effects of serotonin neurotoxins on the nigrostriatal dopamine system: A comparison of injection sites
23. Effect of the serotonin reuptake inhibitor fluoxetine on corticotropin-releasing factor and vasopressin secretion into hypophysial portal blood
24. Buspirone: Action on serotonin receptors in calf hippocampus
25. Binding of the putative anxiolytic TVX Q 7821 to hippocampal 5-hydroxytryptamine (5-HT) recognition sites
26. Treatment of spontaneous panic attacks with chlorimipramine
27. Behavioral inhibition induced by electrical stimulation of the median raphe nucleus of the rat
28. A rating scale for depression
29. Diagnosis and ratings of anxiety
30. Serotonergic function in depression: Prolactin response to intravenous tryptophan in depressed patients and healthy subjects
31. The Geller Conflict Test: A model of anxiety and a screening procedure for anxiolytics
32. Effects of m-chlorophenylpiperazine on receptor binding and brain metabolism of monoamines in rats
33. Effect of melatonin and serotonin on the release of FSH and prolactin
34. Participation of serotonin containing neurons in the suckling-induced rise in plasma prolactin levels in lactating rats
35. The interaction of serotonergic and dopaminergic systems on prolactin secretion in the rat
36. Specific 3H-Imipramine binding in human platelets
37. Tritiated imipramine binding to platelets is decreased in patients with agoraphobia
38. Role of biogenic amines in control of anterior pituitary hormones
39. Hypothalamic hypophysiotropic hormones and neurotransmitter regulation: current views
40. Effect of L
41. Neuroendocrine effects of m-Chlorophenylpiperazine, a serotonin agonist, in humans
42. The effect of ovarian steroids on hypothalamic 5-hydroxy-tryptamine neuronal activity
43. Effect of benzodiazepines on central serotonergic neuron systems
44. Demonstration of specific “high affinity” binding sites for 3H-Imipramine on human platelets
45. Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors
46. Quantitative Autoradiographic Mapping of serotonin receptors in the rat brain. II. Serotonin-2 receptors
47. Selective labeling of 5-HT 1A and 5-HT1B binding sites in bovine brain
48. Sensory stimuli differentially affect in vivo nigral and striatal [3H] serotonin release in the cat
49. m-Chlorophenylpiperazine: A central serotonin agonist causing powerful anorexia in rats
50. Lysteric acid diethylamide-and mescaline-induced attenuation of the effect of punishment in the rat
51. Determination of selective and nonselective compounds for the 5-HT1A and 5-HT1B receptor subtypes in rat frontal cortex
52. Behavioral studies to differentiate anxiolytic and sedative activity of the tranquilizing drugs
53. Chlordiazepoxide reduces in vivo serotonin release in the basal ganglia of encephale isole but not anesthetized cats: Evidence for a dorsal raphe site of action
54. Anti-anxiety action of benzodiazepines: Decrease in activity of serotonin neurons in the punishment system
55. Benzodiazepines: Behavioral and neurochemical mechanisms
56. Distribution of serotonin-immunoreactivity in the central nervous system of the rat-cell bodies and terminals
57. Attenuation of induced-anxiety in rats by chlordiazepoxide: Role of raphe dorsalis benzodiazepine binding sites and serotoninergic neurons
58. Brain serotonin receptors as a target for the putative anxiolytic TVX Q 7821
59. The effects of benzodiazepines and serotonergic manipulations on punished responding
60. Fear and anxiety: Relationship to noradrenergic function
61. Pharmacological evidence that serotonergic stimulation of prolactin secretion is mediated via the dorsal raphe nucleus
62. Evidence that serotonergic neurons in the dorsal raphe nucleus exert a stimulatory effect on the secretion of renin but not of corticosterone
63. Serotonergic stimulation of prolactin and corticosterone secretion is mediated by different pathways from the mediobasal hypothalamus
64. Iontophorelic and systemic administration of the nonbenzodiazepine anxiolytic drug buspirone causes inhibition of serotonergic dorsal raphe neurons in rats
65. Monoamines and histamine in regulation of anterior pituitary secretion
66. Benzodiazepines: Anxiety-reducing activity by reduction of serotonin turnover in the brain
67. Treatment of phobias: Comparison of imipramine and placebo